Ilyang Pharmaceutical Co Ltd (007575) — Financial Flexibility Index
Ilyang Pharmaceutical Co Ltd (007575) has a Financial Flexibility Index of 0.03x as of June 2025. Free cash flow of ₩5.58 Billion (operating CF ₩2.26 Billion minus capex ₩3.32 Billion) represents 0% of total liabilities (₩205.41 Billion). Check Ilyang Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ilyang Pharmaceutical Co Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Ilyang Pharmaceutical Co Ltd across 11 annual periods. See Ilyang Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ilyang Pharmaceutical Co Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Ilyang Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market value of Ilyang Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.24x | ₩46.24 Billion | ₩5.61 Billion | ₩189.63 Billion | ▲ +82.1% |
| 2023 | 0.13x | ₩21.45 Billion | ₩14.62 Billion | ₩160.25 Billion | ▼ -18.8% |
| 2022 | 0.16x | ₩34.02 Billion | ₩29.94 Billion | ₩206.33 Billion | ▼ -54.1% |
| 2021 | 0.36x | ₩79.93 Billion | ₩67.02 Billion | ₩222.51 Billion | ▲ +3.1% |
| 2020 | 0.35x | ₩67.66 Billion | ₩57.48 Billion | ₩194.19 Billion | ▲ +95.0% |
| 2019 | 0.18x | ₩38.37 Billion | ₩36.19 Billion | ₩214.72 Billion | ▲ +67.9% |
| 2018 | 0.11x | ₩23.67 Billion | ₩22.12 Billion | ₩222.37 Billion | ▼ -29.0% |
| 2017 | 0.15x | ₩33.81 Billion | ₩30.03 Billion | ₩225.39 Billion | ▼ -14.0% |
| 2016 | 0.17x | ₩37.29 Billion | ₩26.98 Billion | ₩213.91 Billion | ▼ -31.7% |
| 2015 | 0.26x | ₩56.35 Billion | ₩40.27 Billion | ₩220.62 Billion | ▲ +94.3% |
| 2014 | 0.13x | ₩32.51 Billion | ₩18.63 Billion | ₩247.37 Billion | — |